Fingerprint
Dive into the research topics of 'Phase I and pharmacodynamic study of 17-(allylamino)-17- demethoxygeldanamycin in adult patients with refractory advanced cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I and pharmacodynamic study of 17-(allylamino)-17- demethoxygeldanamycin in adult patients with refractory advanced cancers
Ramesh K. Ramanathan, Merrill J. Egorin, Julie L. Eiseman, Suresh Ramalingam, David Friedland, Sanjiv S. Agarwala, S. Percy Ivy, Douglas M. Potter, Gurkamal Chatta, Eleanor G. Zuhowski, Ronald G. Stoller, Cynthia Naret, Jianxia Guo, Chandra P. Belani
Research output: Contribution to journal › Article › peer-review
78
Scopus
citations